OpSens Announces 1,000th SavvyWire® Procedure

Quebec City, Quebec, April 5, 2023 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, announced a significant milestone for the Company as the SavvyWire has been successfully used by physicians in 1,000 procedures. The SavvyWire is OpSens‘ sensor-guided solution for transcatheter aortic valve replacement procedures, TAVR or TAVI, to treat aortic valve stenosis.

“The successful use of the SavvyWire in 1,000 patients marks an important milestone towards full-scale commercialization of our innovative device.  The early commercialization phase is progressing steadily and the impressive number of procedures completed demonstrates the acceptance and relevance of the SavvyWire within the structural heart market” said Louis Laflamme, President and Chief Executive Officer of OpSens.

“We are gaining positive traction in the U.S. and Canada with our proprietary 3-in-1 solution for TAVR  procedures.  Our sales team is operating at a high level as they educate cardiologists on the benefits of the SavvyWire to expand the number of accounts and drive adoption.  Additionally, signing a GPO agreement last month with one of the largest group purchasing organizations in the United States and SavvyWire being featured in two live case broadcasts during the CRT conference is expected to drive continuous growth going forward,” Mr. Laflamme concluded.

The SavvyWire is the first and only Sensor-Guided solution for TAVR procedures to treat aortic valve stenosis. It uniquely provides a 3-in-1 solution for stable aortic valve delivery and positioning, continuous accurate hemodynamic measurement during the procedure, and reliable left ventricular pacing without the need for adjunct devices or venous access.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    OpSens Medical. (2023, April 19). OpSens Announces 1,000th SavvyWire® Procedure. AZoSensors. Retrieved on May 30, 2024 from https://www.azosensors.com/news.aspx?newsID=15439.

  • MLA

    OpSens Medical. "OpSens Announces 1,000th SavvyWire® Procedure". AZoSensors. 30 May 2024. <https://www.azosensors.com/news.aspx?newsID=15439>.

  • Chicago

    OpSens Medical. "OpSens Announces 1,000th SavvyWire® Procedure". AZoSensors. https://www.azosensors.com/news.aspx?newsID=15439. (accessed May 30, 2024).

  • Harvard

    OpSens Medical. 2023. OpSens Announces 1,000th SavvyWire® Procedure. AZoSensors, viewed 30 May 2024, https://www.azosensors.com/news.aspx?newsID=15439.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.